HIMS gains over 4% as shares trade above all major moving averages

Traders Union
All News
Financial News
Hims & hers health rises 4.21% today

Highlights

Hims & Hers Health maintains a strong bullish trend, trading above all major moving averages across timeframes.
Momentum indicators confirm buyer dominance and continued strength, with minimal risk of an imminent downside move.
Price is expected to consolidate within the $34.71 to $38.19 range; breakout above $38.19 signals further gains, while a drop below $36.4 signals weakness.

Anton Kharitonov, expert at Traders Union, notes that Hims & Hers Health shows persistent bullish momentum, with price action firmly above all major moving averages. He remains cautious since there is no supportive news flow on the target dates, which limits confidence in the sustainability of recent gains. Kharitonov points to a potential mismatch between technical strength and lack of sentiment or fundamental drivers. He also highlights diverging oscillator readings and warns that a drop below $36.4 could trigger selling. "Despite technical positivity, I see risk in the absence of fresh news drivers and would closely monitor any downside move for reversal signs."

Viktoras Karapetjanc, expert at Traders Union, sees further upside as the bullish structure remains intact for Hims & Hers Health. He emphasizes that consistent buying pressure and price action above all key averages signal investor confidence and robust demand. Karapetjanc believes the broad market offers multiple setups in similarly strong trends, and expects further growth if resistance at $38.19 is surpassed. "Momentum and technicals confirm opportunity — I foresee additional gains if bulls retain control above support."

Parshwa Turakhiya, analyst, highlights that bullish momentum dominates with clear short-term setups emerging from strong intraday buyer control. He notes, however, that the low Stochastic RSI warns of a possible pullback, suggesting traders should watch for quick rotations. Turakhiya stresses the importance of monitoring both support at $36.4 and resistance at $38.19 for confirmation. "The sentiment remains constructive for now, but swift moves near key levels may bring fast trading opportunities this week."

Technical strength confirmed as multiple indicators signal buyer control

Hims & Hers Health is trading above its 20-day ($34.36), 50-day ($29.39), and 200-day ($32) moving averages, confirming a bullish bias across all major timeframes. The nearest support is established at $36.4, with resistance at $38.19 and the Ichimoku Kijun at $32.24 backing a sustained upward trend. Momentum remains firmly positive, as both MACD and ADX signal strong bullish conditions. The RSI stands at 57.98, indicating a healthy buy bias without approaching overbought territory. However, a Stochastic RSI of 15.19 highlights an intraday oversold reading, showing some divergence among oscillators. Bull/Bear Power registers at 0.6, confirming intraday buyer dominance alongside a $1.48 gain and 3.39% session volatility, with price action near the daily high.

Earlier, analysts noted that renewed institutional interest and improved technicals suggested rising bullish momentum for Hims & Hers Health. The current uptrend, marked by strong confirmation across all major moving averages and positive momentum signals, shifts immediate focus to a potential breakout above $38.19 as the next catalyst for further upside.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.